Redfund Capital Corp. (CSE:LOAN, Frankfurt:O3X4, OTC:PNNRF) (Redfund Capital or the “Company”) is pleased to announce that Wahupta Ventures Inc. (“Wahupta”) is in the process of filing a listing statement to a public exchange.
Redfund Capital is assisting Wahupta Ventures prepare a listing statement to be filed to a regulated public exchange. While it is the intention of Wahupta to list their shares this fall 2019, they will be required to meet all regulatory and listing requirements before trading commences in their shares. A financing will accompany their public listing statement.
Wahupta Hemp Crop Update:
At the beginning of June, Wahupta’s contracted farmers began planting CBD rich hemp seeds on nearly 8,000 acres in Saskatchewan, Manitoba and British Columbia. In Manitoba alone approximately 3650 acres were planted and anticipated yield is 2500 pounds per acre, for a projected crop over 9,000,000 pounds of biomass. The Winnipeg crop which is growing steadily and presently near heights of 5 feet already with 6-8 weeks left until the 2019 fall crop harvest. Summer weather conditions in the prairies may affect total yield and crop updates are provided to Wahupta weekly. In Saskatchewan over 4000 acres were seeded for hemp and the crop is progressing nicely, in British Columbia approximately 50 acres planted, and in Western Ontario a test crop of 35 acres.
Additionally, Wahupta harvested in 2018 approximately 2 million pounds of hemp biomass which is presently being reviewed and tested by several Canadian licensed cannabis producers to joint venture toll processing agreements as the Canada hemp industry prepares for fall legalization of specific CBD product lines.
“Cultivation of industrial hemp has been permitted in Canada since 1998 and is currently regulated by Health Canada under the Cannabis Act. Health Canada licenses the cultivation of hemp under the Industrial Hemp Regulations. The Canadian Food Inspection Agency’s (CFIA) regulates the import, export, certification and grading of industrial hemp seed.”
“A new Canadian hemp leader being our first breakout company preparing a listing to a public market exchange is exciting for Redfund and a wonderful upside potential for our shareholders. We have always believed in the management team at Wahupta and look forward to helping them reach beyond Canada to the global markets once regulations permits. Wahupta’s competitive advantage of being one of the very first hemp crops in Canada has its challenges. Few in the global capital markets understand that Canada does not permit importation of hemp, that there is a specific Health Canada List of Approved Cultivars and seeds with low CBD %, and that hemp is as regulated in Canada as cannabis. As well, Canada Health is just beginning to pass laws for specific CBD product-lines. Congratulations to Wahupta and their shareholders; job well done!” stated Meris Kott, CEO, Redfund Capital Corp.
“I would like to take this opportunity to thank our shareholders for their confidence and continued support in our mission to build a best-in-class merchant bank focused on incubating, advising and providing capital to help finance medical cannabis, CBD and hemp companies. We are excited to mark the beginning of this new chapter and together watching the opportunity before us as one of our portfolio clients strive to make a meaningful impact in the Canadian hemp sector,” Meris Kott, CEO, Redfund Capital Corp.
About Redfund Capital Corp.
Redfund intends to provide debt and equity funding in the mid-to-late stages of a target company’s development, or in technologies that are developed and validated by revenues. The present focus of the merchant bank is on medical cannabis, hemp and CBD-related, healthcare-related target companies.
For further information please visit www.redfundcapital.com
For more information on Redfund Capital contact
Meris Kott CEO 604.484.8989
Further information about the Company is available on www.SEDAR.com under the Company’s profile.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this release may constitute “forward–looking statements” or “forward-looking information” (collectively “forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated”, “anticipates” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, the Property, financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.
Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.
The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement
Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination
Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces that as part of the equity fundraise announced yesterday, Antony Calamita and Andrew Male, Directors of the Company, subscribed for 285,714 Ordinary Shares and 1,428,571 Ordinary Shares respectively. The subscriptions are at a price of 3.5 pence per ordinary share for a total of £60,000. Following these subscriptions, Antony Calamita is now interested in 54,385,714 Ordinary Shares, representing 8.61% of the Company’s share capital as increased by the fundraising, and Andrew Male is now interested in 6,138,196 Ordinary Shares, representing 0.97% of the Company’s issued share capital as increased by the fundraising
Further, the timetable for receipt of applications under the Broker Option, which was also announced yesterday, has been extended until 5:00 pm 9 April 2021 to capture additional interest which was unable to be completed yesterday.
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign.
In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the Meeting via teleconference and will not be permitted to attend the Meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders.
Gage Cannabis Announces Exclusive Partnership With Blue River to Bring Award-Winning Cannabis Extracts to Michigan
Gage Growth Corp. (“Gage” or the “Company”) (CSE:GAGE), a leading high-quality craft cannabis brand and operator in Michigan, announced today that it has signed an agreement with Blue River™ Extracts & Terpenes (“Blue River™”) to bring the brand’s award-winning solventless technology and other trademark branded products to the state’s medical patients and cannabis consumers. The Company will have exclusive rights to Blue River™’s premium product offerings in Michigan.